Literature DB >> 8729772

HTLV-I associated uveitis, myelopathy, rheumatoid arthritis and Sjögren's syndrome.

S R Pinheiro1, M A Lana-Peixoto, A B Proietti, F Oréfice, M V Lima-Martins, F A Proietti.   

Abstract

A 62 year-old white female presented with a 10-year-history of slowly progressive spastic paraparesis, pain and dysesthesia in the lower limbs and sphincter disturbance. A few years after the onset of the neurologic symptoms she developped migratory arthritis with swelling of the knees and pain on palpation of knees and fingers, dry eyes, mouth and skin. Two months before admission she presented bilateral nongranulomatous anterior uveitis. Examination revealed spastic paraparesis with bilateral Babinski sign, a decreased sensation level below L3, decreased vibration sense in the lower extremities, and a postural tremor of the upper limbs. Laboratory work-up disclosed HTLV-I positive tests in the blood and cerebrospinal fluid (CSF), and a mild pleocytosis in the CSF with a normal protein content. Nerve conduction velocity studies were normal. The present case shows the association of uveitis, arthritis and Sjögren's syndrome in a patient with tropical spastic paraparesis/human T-cell lymphotropic virus type I (HTLV-I) associated myelopathy (TSP/HAM), and illustrates the wide spectrum of clinical manifestations which may accompany this infection with this virus.

Entities:  

Mesh:

Year:  1995        PMID: 8729772     DOI: 10.1590/s0004-282x1995000500011

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  7 in total

1.  Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1.

Authors:  Ana Karina Ferraz-Chaoui; Ajax Mercês Atta; Maria Luiza Sousa Atta; Bernardo Galvão-Castro; Mittermayer B Santiago
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

Review 2.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Hematological manifestations of human T lymphotropic virus type 1 infection: a possible association with autoimmune myelofibrosis.

Authors:  Ana Ciminelli; Frederico Melo; Marie-Christine Copin; Anna Bárbara Carneiro-Proietti; Suely Meireles Rezende
Journal:  Rev Bras Hematol Hemoter       Date:  2015-10-09

4.  Association of Sicca Syndrome with Proviral Load and Proinflammatory Cytokines in HTLV-1 Infection.

Authors:  Clara Mônica Lima; Silvane Santos; Adriana Dourado; Natália B Carvalho; Valéria Bittencourt; Marcus Miranda Lessa; Isadora Siqueira; Edgar M Carvalho
Journal:  J Immunol Res       Date:  2016-01-19       Impact factor: 4.818

5.  Prevalence and Risk Factors for HTLV-1/2 Infection in Quilombo Remnant Communities Living in the Brazilian Amazon.

Authors:  Wandrey Roberto Dos Santos Brito; Greice de Lemos Cardoso-Costa; Lourival Marques Roland Junior; Keise Adrielle Santos Pereira; Felipe Teixeira Lopes; Bernardo Cintra Dos Santos; Aline Cecy Rocha de Lima; Isabella Nogueira Abreu; Carlos Neandro Cordeiro Lima; Sandra Souza Lima; Izaura M Vieira Cayres Vallinoto; Eduardo José Melo Dos Santos; João Farias Guerreiro; Antonio Carlos Rosário Vallinoto
Journal:  Front Public Health       Date:  2022-03-30

6.  Cardiovascular risk profile in patients with myelopathy associated with HTLV-1.

Authors:  Fabio Luís Silva do Prado; Renata Prado; Ana Marice Teixeira Ladeia
Journal:  Braz J Infect Dis       Date:  2017-03-07       Impact factor: 3.257

7.  Acute Liver Injury Due to T-cell Infiltration into the Liver as an Initial Clinical Finding of Adult T-cell Leukemia/Lymphoma.

Authors:  Keisuke Kakisaka; Yuji Suzuki; Shugo Kowata; Shigeki Ito; Yasuhiro Takikawa
Journal:  Intern Med       Date:  2021-08-01       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.